Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This is a trial to see if deferasirox (pronounced de-fer-a-sir-ox) helps people with myelodysplastic syndrome who have too much iron in their blood due to a lot of blood transfusions.
Recruitment start: 25 May 2010
Recruitment end: 4 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paresh Vyas
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 15 Feb 2016
CRUK internal database number: 6652